ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reinauer, H; Rösen, P | 2 |
2 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Alloxan Diabetes
| Article | Year |
|---|---|
Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats.
Topics: Acyltransferases; Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Experimental; Epoxy Compounds; Ethers, Cyclic; Glucose; Heart; Hypoglycemic Agents; Lipolysis; Male; Myocardium; Perfusion; Rats; Rats, Inbred Strains | 1984 |
Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
Topics: Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Epoxy Compounds; Ethers, Cyclic; Glucose; Glycolysis; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Lactates; Lipolysis; Male; Myocardium; Obesity; Pyruvates; Rats; Rats, Zucker | 1988 |